Selcia Limited Introduces New Prolyl Isomerase Screening Service
11/27/2012 11:50:50 AM
More...
|
Selcia Limited and NeuroVive Pharmaceutical AB Announce Breakthrough in Development of Mitochondrial Energy Regulators
10/8/2012 11:33:30 AM
More...
|
Selcia Limited Exploits in-House IP With Demerger Move
7/30/2012 10:37:22 AM
More...
|
Selcia Limited Celebrates 20 Years Radiolabelling Landmark
6/11/2012 12:05:07 PM
More...
|
Selcia Limited Doubles Capacity of 14C GMP Radiolabelled API Production for Human Studies
11/29/2011 9:30:46 AM
More...
|
Selcia Limited and NeuroVive Pharmaceutical AB to Develop New Mitochondrial Medicines for Chronic and Acute Diseases
9/19/2011 9:29:11 AM
More...
|
Selcia Limited and ExonHit Therapeutics SA Announce Successful Fragment Screening Collaboration
2/28/2011 9:09:53 AM
More...
|
Selcia Limited Appoints Simon Saxby as CEO
2/22/2011 6:29:59 AM
More...
|
Selcia Limited Awarded GMP Certificate for Preparation and Carbon-14 Labelling of APIs for Clinical Trials
12/7/2010 10:26:54 AM
More...
|
Selcia Limited and Gilead Sciences, Inc. (GILD) Extend Liver Disease Drug Discovery Collaboration
11/29/2010 1:00:19 PM
More...
|
|